BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, December 21, 2025
Home » Blogs » BioWorld Perspectives » #BIO2011: A Conventioneer’s Field Guide

BioWorld Perspectives
BioWorld Perspectives RSS FeedRSS

BioWorld

#BIO2011: A Conventioneer’s Field Guide

June 28, 2011
By Tom Wall

WASHINGTON ‑ There’s a sorta funny, kinda snotty article in The Washington Post’s style section today – “Know your conventioneer” – that bills itself as “a handy field guide to help you identify which flock your summer conventioneer belongs to.” The article quotes the head of the Washington Convention Center Authority: “They travel in clusters. And their badges give them away.”

A graphic that is supposed to help District of Columbians identify us, the 300,000 conventioneers who will come to their town this year, asks qualifying questions like, “Are the conventioneers multi-gendered? If the answer is no, the answer is Daughters of the American Revolution. “Are they obsessed with talking about cheesy food?” If yes, they are with the International Dairy Food Association.

What a great idea! So here’s a BIO conventioneers field guide to reminding us what city we’re in:

  • “Does the six-block shuttle bus ride to the convention center take 20 minutes, and doesn’t even make it all the way to the Convention Center? Or pick up from all associated hotels?” If yes, it’s Washington.
  • “During the ride, do you see lots of designer burglar bars on the windows and doors of buildings in transitional neighborhoods?” If yes, it’s Washington.
  • “Does a continental breakfast (bagel or pastry and coffee) cost $14.50?” Well, that could be a lot of big cities. “Do they charge an extra $2 for orange juice?” If yes, it’s Washington.
  • “Does your hotel charge you $12.95 a day for wireless Internet – and say they’ll take it off your bill when you check out because you’re with BIO?” If yes, it’s Washington.
  • “Does it cost $24 to get a half-bottle of Dynamite Merlot from the mini bar?” (I’ve had my share of Merlot, but I wouldn’t say any of it was “dynamite.”) That could be a lot of places. “Do Gummy Bears cost $8?” If yes, it’s Washington.
Clearly, in the capital of the Land of the Free, hardly anything is. I’ve found one exception.

Having a gin and tonic night cap in the hotel bar, the bartender asks me if I’m here for BIO. I tell him yes. He asks if it is about saving the environment. I tell him the parts I’m here for are about new drugs for things like cancer. What follows is a long conversation about his father, in his 80s, who has prostate cancer. Should he have surgery? What would I do?

I give him the disclaimer that I’m no expert, but think the best thing he can do is to ask a lot of questions, get a lot of information, and talk it over with his dad and mom. He thanks me and as I start to leave he asks be if I’d like a glass of wine to take to my room.

“I can take it to my room? Well, sure.” (This is what a South Georgia friend refers to as a “roady.”) “What do I owe you?”

It was on the house.

Makes you appreciate the power of healing.

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 19, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 19, 2025.
  • Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

    HIV research is close to a cure but far from ending the pandemic

    BioWorld
    Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
  • Acute myeloid leukemia illustration

    Apollo’s APL-4098 shows potent antileukemic effects

    BioWorld Science
    Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
  • Illustration of brain with electrical activity background

    ABS-1230 controls seizures in KCNT1-driven severe epilepsy

    BioWorld Science
    Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing